rs201893545
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5
The NM_016247.4(IMPG2):c.370T>C(p.Phe124Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,613,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. F124F) has been classified as Likely benign.
Frequency
Consequence
NM_016247.4 missense
Scores
Clinical Significance
Conservation
Publications
- vitelliform macular dystrophy 5Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- inherited retinal dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- retinitis pigmentosa 56Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- adult-onset foveomacular vitelliform dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152136Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000637 AC: 16AN: 251240 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461628Hom.: 0 Cov.: 32 AF XY: 0.0000591 AC XY: 43AN XY: 727122 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74314 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 124 of the IMPG2 protein (p.Phe124Leu). This variant is present in population databases (rs201893545, gnomAD 0.01%). This missense change has been observed in individual(s) with rod-cone dystrophy or autosomal recessive maculopathy (PMID: 20673862; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3550). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. -
Vitelliform macular dystrophy 5 Pathogenic:1
- -
Retinal dystrophy Pathogenic:1
- -
Retinitis pigmentosa Pathogenic:1
- -
Retinitis pigmentosa 56 Uncertain:1
A heterozygous missense variant was identified, NM_016247.3(IMPG2):c.370T>C in exon 3 of the IMPG2 gene. This substitution is predicted to create a minor amino acid change from a phenylalanine to a leucine at position 124 of the protein; NP_057331.2(IMPG2):p.(Phe124Leu). The phenylalanine at this position has very high conservation (100 vertebrates, UCSC), and is not situated in a known functional domain (NCBI, PDB). In silico software predictions of the pathogenicity of this variant are conflicting (PolyPhen2, FATHMM, MutationAssessor, PROVEAN). The variant is present in the gnomAD population database at a global population frequency of 0.007% (19 heterozygotes, 0 homozygotes) with a European sub-population frequency of 0.01%. This variant has been previously reported as pathogenic (ClinVar; Bandah-Rozenfeld, D. et al. (2010)). Based on information available at the time of curation, this variant has been classified as a VUS with POTENTIAL CLINICAL RELEVANCE. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at